Journal article
A systematic review of biomarkers for disease progression in Parkinson's disease.
- Abstract:
-
BACKGROUND: Using surrogate biomarkers for disease progression as endpoints in neuroprotective clinical trials may help differentiate symptomatic effects of potential neuroprotective agents from true disease-modifying effects. A systematic review was undertaken to determine what biomarkers for disease progression in Parkinson's disease (PD) exist. METHODS: MEDLINE and EMBASE (1950-2010) were searched using five search strategies. Abstracts were assessed to identify papers meriting review in ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, bin, 169.5KB)
-
(Version of record, pdf, 346.6KB)
-
(Version of record, zip, 602.5KB)
-
- Publisher copy:
- 10.1186/1471-2377-13-35
Authors
Funding
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC Neurology Journal website
- Volume:
- 13
- Issue:
- 1
- Article number:
- 35
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1471-2377
- ISSN:
-
1471-2377
- Source identifiers:
-
457553
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:9b5a5e99-5dc5-48c0-a24a-3044df6f66fe
- Local pid:
- pubs:457553
- Deposit date:
- 2014-05-13
Terms of use
- Copyright holder:
- McGhee et al
- Copyright date:
- 2013
- Notes:
- © 2013 McGhee et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record